A Phase III, Double-Blind, Placebo Controlled, Multicenter, Randomized Study of Pracinostat in Combination with AZAcitidine in Patients > 18 Years with Newly Diagnosed Acute Myeloid Leukemia (AML) Unfit for Standard Induction Chemotherapy

Sponsor
Helsinn Healthcare SA

Protocol Number
PRAN 16-52

To Learn More Call
201-510-0910